相关实验视频
Updated: Jun 5, 2025

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
21.8K
双抗血小板与高血小板对比在前后循环中轻微的中风中
1Department of Neurology, General Hospital of Northern Theatre Command, Shenyang, Liaoning, China.
Stroke and vascular neurology
|December 11, 2024
概括
双重抗血小板治疗 (DAPT) 显示,在轻度缺血性中风中,长期结果与阿尔泰相似. DAPT提供了更好的安全性,前后循环中风的出血事件较少.
科学领域:
- 神经学 神经学
- 心血管医学 心血管医学
- 脑卒中研究 脑卒中研究
背景情况:
- 针对急性轻度缺血性中风 (ARTIS) 的抗血小板与R-tPA试验证实,双抗血小板疗法 (DAPT) 对轻微非致残性中风的高血小板疗法没有劣势.
- 进行了二次分析,以评估不同中风地区的治疗效果.
研究的目的:
- 在急性轻度缺血性中风患者中,比较DAPT与阿尔特普拉斯的疗效和安全性,按中风区域分层 (前后循环).
- 评估长期的功能结果,早期的神经改善和安全事件.
主要方法:
- 分析了719名患者,按中风地区分类:566名前循环中风 (ACS) 和153名后循环中风 (PCS).
- 主要结局是卓越的功能结局 (修改的兰金度表0-1在90天). 二次结果包括NIHSS得分的变化和早期的神经改善.
- 安全结果包括症状性脑内出血 (sICH) 和出血事件. 对基线特征进行调整的分析.
主要成果:
- 在ACS患者中,DAPT表现出类似的功能结果 (94.1%与91.7%相比),但与阿尔特相比,SICH和出血事件的风险较低.
- 在PCS患者中,DAPT也显示了类似的功能结果 (91.2%对91.8%),降低了出血事件的风险.
- 阿尔特普拉斯在24小时内改善NIHSS得分和ACS患者早期神经改善方面表现优越.
结论:
- 在轻度缺血性中风中,DAPT是一种安全有效的替代阿尔泰的替代品,在前后循环中风中产生类似的长期功能结果.
- DAPT表现出优越的安全性,降低了出血事件.
- 在ACS早期神经改善中,阿尔特的益处值得进一步研究.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
468
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
468
Anticoagulant Drugs: Low-Molecular-Weight Heparins
616
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
616
Formation of the Platelet Plug
4.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.4K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Clot Retraction and Fibrinolysis
4.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.0K

